Suchergebnisse - "Taub, Jeffrey W"

PubPharm (10)

1

Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax

enthalten in: Biochemical pharmacology | 2024

von Zhao, J. | Wu, S. | Wang, D. | +9

2

Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemia

enthalten in: Cancer | 2020

von Karol, S. | Cooper, T. | Mead, P. | +15

3

Concomitant Use of Panobinostat and Reirradiation in Progressive DIPG : Report of 2 Cases

enthalten in: Journal of pediatric hematology/oncology | 2017

von Wang, Z. | Ge, Y. | Altinok, D. | +6

4

Histone deacetylases 1 and 2 cooperate in regulating BRCA1, CHK1, and RAD51 expression in acute myeloid leukemia cells

enthalten in: Oncotarget | 2017

von Zhao, J. | Xie, C. | Edwards, H. | +3

5

Synergistic antitumor interactions between MK-1775 and panobinostat in preclinical models of pancreatic cancer

enthalten in: Cancer letters | 2015

von Wang, G. | Niu, X. | Zhang, W. | +6

6

Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo

enthalten in: Cancer biology & therapy | 2015

von Qi, W. | Zhang, W. | Edwards, H. | +8

7

Targeting histone deacetylases (HDACs) and Wee1 for treating high-risk neuroblastoma

enthalten in: Pediatric blood & cancer | 2015

von Hanmod, S. | Wang, G. | Edwards, H. | +4

8

Synergistic antitumor interactions between MK-1775 and panobinostat in preclinical models of pancreatic cancer

enthalten in: Cancer letters | 2015

von Wang, G. | Niu, X. | Zhang, W. | +6

9

Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cells

enthalten in: PloS one | 2013

von Wang, G. | Edwards, H. | Caldwell, J. | +5

10

Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51

enthalten in: PloS one | 2013

von Xie, C. | Drenberg, C. | Edwards, H. | +8

1
[1]